HRTX FY 2010 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$147M

FY 2010 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M+3.2% YoY

Gross Profit

$1M100.0% margin

Operating Income

-$10M-763.6% margin

Net Income

-$7M-564.6% margin

EPS (Diluted)

$-3.70

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$6M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$3M

Total Liabilities

$2M

Stockholders' Equity

$1M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$1M	+3.2%
Gross Profit	$1M	$1M	+3.2%
Operating Income	-$10M	-$10M	+3.0%
Net Income	-$7M	-$10M	+26.7%